- Guardant Health ( NASDAQ: GH ) is scheduled to announce Q4 earnings results on Thursday, February 23rd, after market close.
- The consensus EPS Estimate is -$1.16 (-68.1% Y/Y) and the consensus Revenue Estimate is $123.93M (+14.6% Y/Y).
- Over the last 2 years, GH has beaten EPS estimates 50% of the time and has beaten revenue estimates 88% of the time.
- Over the last 3 months, EPS estimates have seen 1 upward revision and 1 downward. Revenue estimates have seen 6 upward revisions and 1 downward.
For further details see:
Guardant Health Q4 2022 Earnings Preview